The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications

Obstetrics and Gynecology

Volumn 88, Issue 5, 1996, Pages 816-822

  Waller, D Kim ^a   Lustig, Linda S ^b   Cunningham, George C ^b   Feuchtbaum, Lisa B ^b   Hook, Ernest B ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MATERNAL SERUM; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; SMALL FOR DATE INFANT; VAGINA BLEEDING;

EID: 0030297079     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00310-9     Document Type: Article

References (33)

1. 1. Burton BK. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein. Obstet Gynecol 1988;72:709-13.
2. 2. Brock DJH, Barron L, Jelen P, Watt M, Scrimgeour JB. Maternal serum alpha-fetoprotein measurements as an early indicator of low birth weight. Lancet 1977;ii:267-70.
3. 3. Wald N, Cuckle H, Stirrat GM, Bennett MJ, Turnbull AC. Maternal serum alpha-fetoprotein and low birth weight. Lancet 1977;ii:268-70.
4. 4. Waller DK, Lustig LS, Smith AH, Hook EB. Alpha-fetoprotein: A biomarker for pregnancy outcome. Epidemiology 1993;4:471-6.
5. 5. Wald NJ, Cuckle HS, Boreham J. Maternal serum alpha-fetoprotein and birth weight. Br J Obstet Gynaecol 1980;87:860-3.
6. 6. Davis RO, Goldenberg RL, Boots L, Hoffman HJ, Copper R, Cutter GR, et al. Elevated levels of maternal serum alpha-fetoprotein are associated with preterm delivery but not with fetal growth retardation. Am J Obstet Gynecol 1992;167:596-601.
7. 7. Milunsky A, Jick S, Bruell CL, MacLaughlin DS, Tsung Y, Jick H, et al. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: New epidemiologic data. Am J Obstet Gynecol 1989;161: 291-7.
8. 8. Williams MA, Hickok DE, Zingheim RW, Luthy DA, Kimelman J, Nyberg DA, et al. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol 1992;167:1032-7.
9. 9. Wenstrom KD, Sipes SL, Williamson RA, Grant SS, Trawick DC, Estile LC. Prediction of pregnancy outcome with single versus serial maternal serum alpha-fetoprotein tests. Am J Obstet Gynecol 1992;167:1529-33.
10. 10. Brock DJH, Barron L, Raab GM. The potential of mid-trimester maternal plasma alpha-fetoprotein measurement in predicting infants of low birth weight. Br J Obstet Gynaecol 1980;87:582-5.
11. 11. Evans J, Stokes IM. Outcome of pregnancies associated with raised serum and normal amniotic fluid alpha-fetoprotein concentrations. BMJ 1984;288:1494.
12. 12. Chard T, Rice A, Kitau MJ, Hird V, Grudzinskas JG, Nysenbaum AM. Mid-trimester levels of alpha-fetoprotein in the screening of low birth weight. Br J Obstet Gynaecol 1986;93:36-8.
13. 13. Wenstrom K, Owen J, Davis R, Brumfield CG. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein. Obstet Gynecol 1996;87:213-6.
14. 14. Brazerol WF, Grover S, Donnenfeld AE. Unexplained elevated maternal serum alpha-fetoprotein levels and perinatal outcome in an urban clinic population. Am J Obstet Gynecol 1994;171:1030-5.
15. 15. Purdie DW, Young JL, Guthrie KA, Picton CE. Fetal growth achievement and elevated maternal serum alpha-fetoprotein. Br J Obstet Gynaecol 1983;90:433-6.
16. 16. Mariona FG, Hassan MM, Syner FN, Chik LC, Sokol RJ. Maternal serum alpha-fetoprotein and fetal growth. J Perinatal Med 1984; 12:179-83.
17. 17. Burton BK, Dillard RG. Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein. Pediatrics 1986;77:582-6.
18. 18. Adams MJ Jr., Windham GC, James LM, Greenberg F, Clayton-Hopkins JA, Reimer CB, et al. Clinical interpretation of maternal serum alpha-fetoprotein concentrations. Am J Obstet Gynecol 1984;148:241-54.
19. 19. Evans MI, Belsky R, Greb A, Dvorin E, Drugan A. Wide variation in maternal serum alpha-fetoprotein reports in one metropolitan area: Concerns for the quality of prenatal testing. Obstet Gynecol 1988;72:342-5.
20. 20. Wajda A, Roos LL, Layefsky M, Singleton JA. Record linkage strategies: Part II. Portable software and deterministic matching. Methods Inf Med 1991;30:210-4.
21. 21. Lustig L, Clarke S, Cunningham G, Schonberg R, Tompkinson G. California's experience with low MSAFP results. Am J Med Genet 1988;31:211-22.
22. 22. Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris FD, Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol 1982;59:624-32.
23. 23. Mantel N. Chi-square tests with one degree of freedom: Extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
24. 24. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika 1967;54: 167-79.
25. 25. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-94.
26. 26. Simpson JL, Palomaki GE, Mercer B, Haddow JE, Andersen R, Sibai B, et al. Associations between adverse perinatal outcome and serially obtained second and third trimester maternal serum alpha-fetoprotein measurements. Am J Obstet Gynecol 1996;173:1742-8.
27. 27. Piper JM, Mitchel EF, Snowden M, Hall C, Adams M, Taylor P. Validation of 1989 Tennessee birth certificates using maternal and newborn hospital records. Am J Epidemiol 1993;137:758-68.
28. 28. Bernstein IM, Barth RA, Miller R, Capeless EL. Elevated maternal serum alpha-fetoprotein associated with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding and pregnancy outcome in the absence of fetal anomalies. Obstet Gynecol 1992;79: 71-4.
29. 29. Waller DK, Lustig LS, Cunningham GC, Golbus M, Hook EB. Second trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 1991;335:6-10.
30. 30. Boyd PA. Why might maternal serum alpha-fetoprotein be high in pregnancies in which the fetus is normally formed? Br J Obstet Gynaecol 1992;99:93-5.
31. 31. Penrose LS. Outline of human genetics. London: Heinemann, 1985.
32. 32. Waller KD, Lustig LS, Hook EB. Does fetal growth retardation explain the association between Down syndrome and low levels of maternal serum alpha-fetoprotein? Prenat Diagn 1992;12:854-5.
33. 33. Gabbe SG. Intrauterine growth retardation. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics: Normal and problem pregnancies. New York: Churchill Livingstone, 1986:772.